about
Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patientsClinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine.Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.A Web- and Mobile-Based Intervention for Women Treated for Breast Cancer to Manage Chronic Pain and Symptoms Related to Lymphedema: Randomized Clinical Trial Rationale and ProtocolTransdermal matrix fentanyl membrane patch (matrifen): in severe cancer-related chronic pain.Chronic treatment-related pain in cancer survivors.Cancer breakthrough pain in the presence of cancer-related chronic pain: fact versus perceptions of health-care providers and patients.Hypnosis for the management of chronic and cancer procedure-related pain in children.Chronic Cancer-Related Pain: Continuous Perineural Infusion of Local Anesthetics as Alternative to Systemic Analgesic Drugs.Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial.[Patients with cancer-related pain and other chronic pain. Priorities and assessment]A Typology of Predictive Risk Factors for Non-Adherent Medication-Related Behaviors among Chronic Non-Cancer Pain Patients Prescribed Opioids: A Cohort Study.A prospective evaluation of health-related quality of life in Hong Kong Chinese patients with chronic non-cancer pain.Chronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patients.Factors related to post-treatment chronic pain in breast cancer survivors: the interference of pain with life functions.Cancer-related chronic pain: examining quality of life in diverse cancer survivors.Prevalence, severity, and chronicity of pain and general health-related quality of life in patients with localized prostate cancer.Somatic symptoms in patients with chronic non-cancer-related and cancer-related pain.Treatment-related factors predisposing to chronic pain in patients with breast cancer--a multivariate approach.Cancer-related chronic pain: investigation of the novel analgesic drug candidate cebranopadol in a randomized, double-blind, non-inferiority trialA Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer PainA Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic PainSafety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer PainSafety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)Cancer Chronic Pain Predicted by Emotional and Cognitive Status
P921
Q34115133-b5e6c86a-1493-406e-9cac-40ac925f78b1Q34783638-bff14d12-4a1f-4959-8782-7c3c5c78965bQ35573005-47b675a1-4ab0-4d6d-a2d2-4258c0a87b78Q35586312-c2a3df2e-9d42-4bea-a83f-85c615165419Q36548023-83e88d8f-7422-48d3-a16b-8534bed8b661Q37263198-8e9e3143-0b7d-4024-b01c-e9387216cde1Q37805226-5f5395ed-3d89-4ba0-a0bc-81bf87482b97Q37832232-8d51ce47-22d7-4e3d-99c4-c454505ab3f5Q38037145-1414e917-b535-43ac-9519-529ee2edb9a7Q39171104-bd267cb5-6e70-4231-b85c-dac10e997e0cQ39331443-368beb67-ddb0-41af-ad40-2a984bbd99a4Q39397011-69cae86a-2a54-41ad-a4e3-e19f779b06deQ39467413-31375f79-8063-4c32-a723-5a8fcd7d352aQ39894091-dbdb9742-df5c-4e09-9f07-2d1c71da0025Q47269261-2382e429-fcad-408f-b060-f9e0a5322c9aQ48451240-0d9d9409-fae4-4c99-ad6f-c86b154fc4cdQ48494089-2ec8eed6-54db-4af6-ac93-0ecaa3fe61adQ48686500-247a2a15-fd39-4816-bb9b-8cfc1182170bQ50888062-7f7860e2-ae55-4934-a43e-ef75e8e943e6Q50965120-19b545c2-9e80-41ed-b660-c63a31984f1aQ51551032-7a1b7f75-cce0-44cc-8437-d194444fec31Q58542262-08efd465-f9b1-4262-9acb-3d4d68089c28Q65385325-21498E1A-821B-4C67-9843-9F6CBAC0486FQ65385354-1DF521EE-2FB5-4BD2-80A1-88257A43CC3DQ65385369-B951B86D-F262-4377-BFDA-02FDB6BB74B1Q65385377-7D84DCF0-516A-4342-9656-72CCDAD47011Q66402902-BD957869-3DC3-4CCD-9689-CD1FFFBD235F
P921
description
defined as cancer or treatment related visceral, musculoskeletal, or bony pain
@en
name
chronic cancer related pain
@en
type
label
chronic cancer related pain
@en
altLabel
MG30.1
@en
chronic cancer pain
@en
prefLabel
chronic cancer related pain
@en